Globus Medical, Inc. (GMED) Is At $49.82 Formed Wedge; LIFESTYLE INTERNATIONAL HOLDINGS LTD (LFSYF) Shorts Raised By 54.55%

Globus Medical, Inc. (NYSE:GMED) Logo

Globus Medical, Inc. (GMED) formed wedge up with $54.30 target or 9.00% above today’s $49.82 share price. Globus Medical, Inc. (GMED) has $4.82 billion valuation. The stock increased 1.14% or $0.56 during the last trading session, reaching $49.82. About 800,897 shares traded or 23.50% up from the average. Globus Medical, Inc. (NYSE:GMED) has risen 65.36% since April 2, 2017 and is uptrending. It has outperformed by 53.81% the S&P500.

LIFESTYLE INTERNATIONAL HOLDINGS LTD (OTCMKTS:LFSYF) had an increase of 54.55% in short interest. LFSYF’s SI was 20,400 shares in April as released by FINRA. Its up 54.55% from 13,200 shares previously. With 10,600 avg volume, 2 days are for LIFESTYLE INTERNATIONAL HOLDINGS LTD (OTCMKTS:LFSYF)’s short sellers to cover LFSYF’s short positions. The SI to LIFESTYLE INTERNATIONAL HOLDINGS LTD’s float is 0.01%. It closed at $1.6 lastly. It is down 0.00% since April 2, 2017 and is . It has underperformed by 11.55% the S&P500.

Among 15 analysts covering Globus Medical Inc (NYSE:GMED), 9 have Buy rating, 2 Sell and 4 Hold. Therefore 60% are positive. Globus Medical Inc has $6000 highest and $21 lowest target. $43.11’s average target is -13.47% below currents $49.82 stock price. Globus Medical Inc had 47 analyst reports since August 3, 2015 according to SRatingsIntel. Canaccord Genuity maintained Globus Medical, Inc. (NYSE:GMED) on Thursday, August 3 with “Buy” rating. The rating was maintained by Oppenheimer with “Hold” on Thursday, August 3. The firm earned “Buy” rating on Thursday, January 4 by Canaccord Genuity. The rating was initiated by UBS on Tuesday, September 22 with “Buy”. As per Monday, May 16, the company rating was downgraded by Goldman Sachs. Barclays Capital maintained the stock with “Equalweight” rating in Wednesday, July 27 report. Piper Jaffray maintained Globus Medical, Inc. (NYSE:GMED) on Thursday, August 17 with “Buy” rating. The stock has “Buy” rating by Canaccord Genuity on Thursday, February 22. The firm earned “Buy” rating on Thursday, August 17 by Canaccord Genuity. The stock of Globus Medical, Inc. (NYSE:GMED) has “Buy” rating given on Monday, December 4 by Wells Fargo.

Investors sentiment decreased to 0.99 in Q4 2017. Its down 0.39, from 1.38 in 2017Q3. It is negative, as 26 investors sold Globus Medical, Inc. shares while 83 reduced holdings. 40 funds opened positions while 68 raised stakes. 59.89 million shares or 7.54% less from 64.77 million shares in 2017Q3 were reported. 10,337 are held by Amalgamated Bancorp. Millrace Asset Gp reported 43,500 shares. Reilly Fincl Advisors Ltd reported 472 shares stake. First Interstate National Bank has 0.04% invested in Globus Medical, Inc. (NYSE:GMED). Smithfield invested in 90 shares. Martingale Asset Mngmt Lp owns 14,506 shares. 790 are held by Ftb. Pembroke Management holds 236,500 shares or 1% of its portfolio. Moreover, Gofen And Glossberg Lc Il has 0.11% invested in Globus Medical, Inc. (NYSE:GMED). Moreover, Pub Employees Retirement Association Of Colorado has 0% invested in Globus Medical, Inc. (NYSE:GMED) for 1,624 shares. Meeder Asset Management holds 0% or 180 shares. Wells Fargo And Mn has 676,224 shares for 0.01% of their portfolio. Millennium Management Ltd Liability Co invested 0.02% in Globus Medical, Inc. (NYSE:GMED). 10,588 were accumulated by Commonwealth Of Pennsylvania Pub School Empls Retrmt. Cubist Systematic Strategies Ltd invested in 0% or 1,100 shares.

Analysts await Globus Medical, Inc. (NYSE:GMED) to report earnings on May, 2. They expect $0.36 earnings per share, up 12.50% or $0.04 from last year’s $0.32 per share. GMED’s profit will be $34.79 million for 34.60 P/E if the $0.36 EPS becomes a reality. After $0.38 actual earnings per share reported by Globus Medical, Inc. for the previous quarter, Wall Street now forecasts -5.26% negative EPS growth.

Globus Medical, Inc. (NYSE:GMED) Institutional Positions Chart